Home › Idiopathic Pulmonary Fibrosis › Michigan
Idiopathic Pulmonary Fibrosis clinical trials in Michigan
7 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Michigan.
Cities in Michigan
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Ann Arbor
- Research Site, Detroit
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Henry Ford Health, Detroit
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- University of Michigan Health System - Ann Arbor /ID# 279994, Ann Arbor
- Henry Ford Hospital /ID# 277843, Detroit
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07230288Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Beaumont Hospital, Royal Oak, Royal Oak
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Henry Ford Health, Detroit
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Ann Arbor, MI, Ann Arbor
- WISPer Site in Detroit, MI, Detroit
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.